Clinical Trial Update: Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating sodium bicarbonate to prevent contrast-induced nephropathy in patients at risk for acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Acute Kidney Failure | Phase 3 | Status: UNKNOWN